NCT05691972View on ClinicalTrials.gov

Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

October 26, 2023

Study Completion Date

December 11, 2024

Conditions
Temporal Hollowing
Interventions
DEVICE

Restylane Contour

a sterile, biodegradable, transparent gel of nonanimal cross-linked HA (20 mg/mL) with the addition of lidocaine hydrochloride (3 mg/mL)

Trial Locations (15)

10021

Galderma Research Site, New York

20037

Galderma Research Site, Washington D.C.

27517

Galderma Research Site, Chapel Hill

28405

Galderma Research Site, Wilmington

33146

Galderma Research Site, Coral Gables

33180

Galderma Research Site, Adventura

33437

Galderma Research Site, Boynton Beach

37203

Galderma Research Site, Nashville

70115

Galderma Research Site, New Orleans

85054

Galderma Research Site, Phoenix

90069

Galderma Research Site, Los Angeles

90277

Galderma Research Site, Redondo Beach

91436

Galderma Research Site, Encino

92075

Galderma Research Site, Solana Beach

92083

Galderma Research Site, Vista

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY